COMP <GO>
SCHW vs CME // RETURN ON INVESTED CAPITAL (ROIC)
Charles Schwab Corporation (NYSE) VS. CME Group Inc. (NASDAQ) • 15-METRIC TALLY: SCHW 3
— CME 7
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: CME
LAST: $89.47 (+0.80%) • MKT CAP: $154.72B
roic
0.00%
LAST: $296.42 (+0.81%) • MKT CAP: $106.10B
roic
3.50%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SCHW VS. CME)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SCHW | CME | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 0.00% | 3.50% | -3.50 | CME | /roic <GO> |
| EV/EBITDA & P/E Valuation | 95.0x | 40.2x | +54.80 | CME | /valuation <GO> |
| Free Cash Flow Yield | 5.66% | 3.95% | +1.71 | SCHW | /fcf-yield <GO> |
| Operating Margin | 0.00% | 64.90% | -64.90 | CME | /operating-margins <GO> |
| Net Profit Margin | 0.00% | 62.50% | -62.50 | CME | /net-margins <GO> |
| Revenue Growth (YoY) | 22.00% | 6.40% | +15.60 | SCHW | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.51% | 3.71% | -2.20 | CME | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 34.4 | 57.6 | -23.20 | CME | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.99 | 1.01 | -0.02 | CME | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 24.3x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $154.72B | $106.10B | $48.63B | SCHW | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SCHW REV | CME REV | SCHW GROSS % | CME GROSS % | SCHW FCF | CME FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $23.92B | $6.52B | — | — | $8.76B | $4.19B |
| FY 2024 | $19.61B | $6.13B | — | — | $2.05B | $3.60B |
| FY 2023 | $18.84B | $5.58B | — | — | $18.74B | $3.20B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SCHW // BETA 0.99
CME // BETA 1.01